Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1889)	9/20/2007 11:05:16 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

SSRX Continues on the up-move that started on Sep4. bigcharts.marketwatch.com It has 4Qs of double digit improvements on revenues & triple digit improvements on earnings. The EE for 2007 are around $0.50/shr vs. $0.18/shr in 2006 & for 2008 another 30% improvement is expected.<g> The stock is below its IPO price, but seems that it wants to come out from a cup formation.<g> bigcharts.marketwatch.com Bernard

To: Jibacoa who wrote (1889)	3/6/2008 11:29:25 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

EXAS opened with a large UG & is up 55.5% on volume of > 1,660,000 which is > 10x its ADV bigcharts.marketwatch.com It announced yesterday that the its stool-based DNA technology is included in the updated guidelines for colorectal cancer screening released by the ACS. Pre-cancerous lesions & colorectal Cas., shed cells into the stool. EXACT’s stool-based DNA technology can isolate & amplify the DNA from a stool sample & analyze it for DNA mutations and alterations known to be associated with Cas. Colon & rectal cancers are the most deadly cancer among non-smoking men and women in the U.S. & the 2nd most deadly cancer overall. The stock is responding to the news & the CC this morning. It traded earlier above the Dec 14 H of $3.90 & is trying to get off from the DT coming from its Oct H at $6.17 when it made a 52 wks. H Its longer DT comes from its Sep 2003 H ar $18 <g> bigcharts.marketwatch.com Bernard